Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lekaa Mohammadova"'
Autor:
Kamila Stranska, Karla Plevova, Hana Skuhrova Francova, Hana Skabrahova, Magdalena von Jagwitz-Biegnitz, Lenka Radova, Anna Panovska, Stanislava Hrobkova, Yvona Brychtova, Renata Urbanova, Lukas Smolej, Martin Simkovic, Jana Zuchnicka, Lekaa Mohammadova, Martin Spacek, Jiri Mayer, Sarka Pospisilova, Michael Doubek
Publikováno v:
Biomedical Papers, Vol 164, Iss 4, Pp 425-434 (2020)
Aims: This is a nation-wide survey of chronic lymphocytic leukemia (CLL) patients at six large hematology centers in the Czech Republic. The aim was to identify specific populations, social, and health characteristics of CLL subgroups divided accordi
Externí odkaz:
https://doaj.org/article/98abe80f90664881b5133fa1d14a42e8
Autor:
Hana Skuhrová Francová, Magdalena von Jagwitz-Biegnitz, Anna Panovská, Martin Simkovic, Jana Zuchnická, Stanislava Hrobková, Šárka Pospíšilová, Yvona Brychtová, Michael Doubek, Kamila Stránská, Jiri Mayer, Lenka Radová, Lekaa Mohammadova, Renata Urbanova, Martin Spacek, Hana Škabrahová, Karla Plevová, Lukas Smolej
Publikováno v:
Biomedical Papers, Vol 164, Iss 4, Pp 425-434 (2020)
Aims: This is a nation-wide survey of chronic lymphocytic leukemia (CLL) patients at six large hematology centers in the Czech Republic. The aim was to identify specific populations, social, and health characteristics of CLL subgroups divided accordi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea77ad47a41283f533363a57a7b7311
https://biomed.papers.upol.cz/artkey/bio-202004-0011_profiling-of-biological-and-environmental-risk-factors-in-immunogenetic-subgroups-of-chronic-lymphocytic-leukem.php
https://biomed.papers.upol.cz/artkey/bio-202004-0011_profiling-of-biological-and-environmental-risk-factors-in-immunogenetic-subgroups-of-chronic-lymphocytic-leukem.php
Autor:
Jan Molinský, Anna Panovská, Stanislava Hrobková, Heidi Mocikova, Marek Trněný, Josef Karban, Petra Obrtlikova, Michael Doubek, Lekaa Mohammadova, Martin Simkovic, Jan Novák, Martin Spacek, Lukas Smolej, Eduard Cmunt
Publikováno v:
Leukemia Research. 79:17-21
Chemoimmunotherapy with bendamustine and rituximab is an alternative treatment for elderly patients with CLL. The aim of this observational multicenter study was to prospectively assess efficacy and safety of bendamustine and rituximab in front-line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d56647f698d39829c20907eaea64f80
https://doi.org/10.1016/j.leukres.2019.02.002
https://doi.org/10.1016/j.leukres.2019.02.002